• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    CMC Pharmaceuticals

    Lannett CDMO

    INCOG BioPharma Services

    TaiMed Biologics

    Federal Equipment Company
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    CMC Pharmaceuticals

    Lannett CDMO

    INCOG BioPharma Services

    TaiMed Biologics

    Federal Equipment Company
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Optimizing Drug Solubility

    Selecting excipients for drug solubilization with a new high-throughput screen method

    Optimizing Drug Solubility
    Optimizing Drug Solubility
    Figure 1. Solubility of the six drug candidates in the testing excipients. 15mg/mL was set as the maximum amount. Degradation of the drug is indicated in red.
    Amjad Alhalaweh, Recipharm10.11.17
    Many newly discovered compounds are limited by issues associated with poor water solubility, meaning that drugs do not adequately dissolve in physiological fluids. Poor solubility can lead to low bioavailability resulting in suboptimal drug delivery, and despite possessing superior pharmacological properties, these drug molecules risk withdrawal from development. 

    Solubility is critical in achieving the required concentration of a compound for the desired pharmacological response. In the initial stages of drug design and development, simple liquid formulations are used to evaluate a compound’s pharmacology, pharmacokinetics and toxicology. During this process, compounds that suffer from low aqueous solubility need to be paired with excipients that can adequately solubilize them.1,2 Until recently, the identification of an appropriate excipient has relied on a trial-and-error-based methodology. The time-consuming and expensive nature of this process has paved the way for the development of a new high-throughput screen (HTS) method that can optimize the selection of appropriate solubilization excipients.

    Drug solubility enhancement techniques
    Solubility issues complicate the formulation and development of new chemical entities (NCEs), but there is an array of techniques available to enhance the solubility and improve the bioavailability of these drugs. The strategies include either solid form manipulation using amorphous, salt or cocrystal form, or solvation methods using materials that can solubilize the drug compound such as co-solvents, surfactants or cyclodextrins.3,4 Selection of the solubility method will depend on several factors, including a compound’s unique properties, the physical state of the formulation, the site of adsorption and the required dosage form characteristics. Generally, solvent modifications and carrier systems are the most widely used approaches in developing liquid formulations due to their ability to only impact the solvation characteristics of a compound rather than its solid-state properties and ease of preparation.5

    Exploring a more efficient approach
    While there are many solubilization techniques available to formulation scientists, the trial-and-error-based approach of selecting the right methodology for a compound is both time-consuming and requires a considerable amount of active pharmaceutical ingredient (API) to be used for each test. This makes it an incredibly costly and resource heavy option for drug developers. Furthermore, the risk of missing the best excipient for a compound is high due to the limited experiments and cost associated with performing manual handling.

    To overcome the challenges, a HTS approach has been developed to offer a more cost and time efficient alternative to existing techniques. The aim was to develop a robust, automatic platform that would use minimal amounts of compound to provide conclusive information about a drug’s solubility and stability in a variety of solvents and excipients. To establish the methodology, a large number of experiments were performed to optimize the technique, using a broad screening list of excipients, including water-soluble organic solvents, non-ionic surfactants, water-insoluble lipids, organic liquids/semi solids, cyclodextrins, and phospholipids.6

    Using the approach, different excipients are shown to be most appropriate for varying drug delivery systems. For example, there are marked differences between the list of excipients identified as oral excipients and those considered most suitable for injectables. There is also a need to understand the necessary concentration for each excipient and each drug delivery system. This should be done in line with the Generally Recognized as Safe (GRAS) list of recommended concentrations.

    Selection of an appropriate excipient, or combination of excipients, is critical to the drug formulation process. An incorrect number of excipients could result in pain, haemolysis, or inflammation on administration to a patient. Clearer insight into a compound’s solubility in a wide-range of excipients will assist formulation scientists in ensuring that unwanted side effects are minimized, bringing a more stringent approach to patient safety during drug development.

    Testing the high-throughput screen methodology
    The HTS approach shortens the time necessary to identify which excipients can adequately solubilize a compound, as well as which excipients a compound can remain stable in. Instead of testing every excipient manually, as has been required with previous approaches, this methodology involves multiple tests being undertaken concurrently.

    To develop the method, six commercially available drugs were used with diverse chemical properties. These were tested with 30 excipients, dispensed in 96 well-plates via an automated TECAN-robotic system. During this experimental phase, the plates were shaken for 48-hours to achieve equilibrium.

    The results of the testing process were compared with the solubility measurements achieved using a manual shake flask method (using 15mg of powder and 2mL of excipient). The samples were again shaken for 48-hours, centrifuged and analyzed by high-performance liquid chromatography (HPLC). All experiments were performed in triplicate. This process determined the solubility of the compounds in the excipient, while also detecting any degradation of the compound.

    The results
    The understanding of a compound’s unique physical properties and their impact on different characteristics not only enhances the selection of the most appropriate formulation strategy, but also ensures the most appropriate excipient for the drug delivery system. The solubilization extent for each molecule by each excipient is demonstrated in Figure 1.
    The findings have highlighted that pH dependent solubility is a useful approach for ionizable compounds, especially if it can be combined with another solubilizing excipient. The contribution of solid-state barrier to solubilizing a compound appears to be more pronounced at a cut-off level of the solid-state properties. This has already been determined to some extent by previous research programs7 and is currently being investigated using a larger set of compounds. Before this cut-off, the solubilization of the compound was more compound specific which creates the need to also test on a larger set of excipients.

    The testing phase demonstrated that solubility using the HTS method is not statistically different to the results achieved using a manual approach, this was verified at a 95% confidence interval using a t-test. The platform provides detailed insight on the solubilization capacity of different compounds in varying excipients, while also providing formulation scientists with information on the stability of a compound in each excipient tested, as well as in water, and acidic and basic buffers.

    Establishing the HTS method has provided an approach that overcomes many of the challenges associated with trial-and-error based manual techniques. In addition to being more cost effective and using minimal volumes of materials, the approach can achieve results in 3-5 days, making it a much faster alternative to traditional techniques.

    Final thought
    Therapeutic effectiveness of a drug depends upon the solubility of drug molecules, with low aqueous solubility being regarded as one of the most challenging aspects in the formulation of NCEs. An understanding of the solubility behavior of a compound is a vital aspect of pre-formulation testing, and these problems can be readily addressed with the identification of an appropriate solubility technique. Selection of the right solubility excipient will come down to several factors relating to a drug’s unique characteristics. By adopting a HTS methodology, formulation scientists can not only identify the ideal excipient for a compound, but can do so in a more efficient and cost-effective way, while minimizing the amount of API required to achieve accurate results. By optimizing formulation design, the HTS method can bring improved timelines while ensuring patient safety, and enhancing the pathway for the development of new drugs. 

    References
    1. Li, P., & Zhao, L. (2007). Developing early formulations: practice and perspective. International Journal of Pharmaceutics, 341(1), 1-19.
    2. Dahan, A., Beig, A., Lindley, D., & Miller, J. M. (2016). The solubility–permeability interplay and oral drug formulation design: Two heads are better than one. Advanced drug delivery reviews, 101, 99-107.
    3. Alhalaweh, A., Bergström, C. A., & Taylor, L. S. (2016). Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations. Journal of Controlled Release, 229, 172-182.
    4. Miyako, Y., Khalef, N., Matsuzaki, K., & Pinal, R. (2010). Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. International journal of pharmaceutics, 393(1), 48-54.
    5. Alhalaweh, A., Roy, L., Rodríguez-Hornedo, N., & Velaga, S. P. (2012). pH-dependent solubility of indomethacin–saccharin and carbamazepine–saccharin cocrystals in aqueous media. Molecular pharmaceutics, 9(9), 2605-2612
    6. Strickley, R. G. (2004). Solubilizing excipients in oral and injectable formulations. Pharmaceutical research, 21(2), 201-230
    7. Persson, L. C., Porter, C. J., Charman, W. N., & Bergström, C. A. (2013). Computational prediction of drug solubility in lipid based formulation excipients. Pharmaceutical research, 30(12), 3225-3237.

    Dr. Amjad Alhalaweh, Ph.D., is a research scientist at Recipharm’s development facility in Uppsala, Sweden. He is responsible for developing solutions for complex formulation challenges for both newly discovered compounds and existing drugs, along with finding new, cost-effective approaches for formulation design. He has specific expertise in the development of liquid formulations through understanding of the solubilization mechanism of different excipients, crystallization of a compound, solid-state characterization and solid form selection. He also delivers lectures at Uppsala University on the formulation of poorly soluble compounds. An active member of several professional bodies including the Controlled Release Society, the American Association of Pharmaceutical Science and the Swedish Association of Pharmaceutical Science, Amjad is also a registered pharmacist with the Syrian Pharmaceutical Association. Dr. Alhalaweh can be reached at amjad.alhalaweh@recipharm.com.
    Related Searches
    • liquids
    • it
    • Dosage
    • Stability
    Suggested For You
    API Development Trends API Development Trends
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    Spray Drying: A Proven Approach to Enhance the Solubility of APIs Spray Drying: A Proven Approach to Enhance the Solubility of APIs
    Global Outsourcing Trends Global Outsourcing Trends
    Ardena Acquires Idifarma from Suanfarma and Sodena Ardena Acquires Idifarma from Suanfarma and Sodena
    Bachem and Novo Nordisk Redesign SPPS for Green Chemistry Bachem and Novo Nordisk Redesign SPPS for Green Chemistry
    Solving Solubility Challenges for a Novel Oncology Drug Solving Solubility Challenges for a Novel Oncology Drug
    Nanoform, Boehringer Ingelheim Sign Master Services Agreement Nanoform, Boehringer Ingelheim Sign Master Services Agreement
    Host Cell Impurities, Bioassays, Micro-Flow Imaging Host Cell Impurities, Bioassays, Micro-Flow Imaging
    Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm
    Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion
    Small Molecule Drug Development Trends Small Molecule Drug Development Trends
    Metrics Names Stephanie Emory Associate Director of Pharma Development Metrics Names Stephanie Emory Associate Director of Pharma Development
    Ascendia Pharmaceuticals Poised for Expansion Ascendia Pharmaceuticals Poised for Expansion
    Outsourcing Solid Dosage Manufacturing Outsourcing Solid Dosage Manufacturing

    Related Features

    • APIs | Drug Development
      API Development Trends

      API Development Trends

      Why is it important to consider solid form in API development?
      John Mykytiuk, Jamie Marshall and Andrew Blythe-Dickens, Sterling Pharma Solutions 09.09.21

    • Analytical Services | Laboratory Testing
      Raman Spectroscopy for Pharmaceutical Analysis & Quality Control

      Raman Spectroscopy for Pharmaceutical Analysis & Quality Control

      Raman spectroscopy helps ensure quality along the pharma supply chain of materials—from incoming raw materials through to finished product.
      Jacques Ledru, Head of Characterization, Catalent, Nottingham 09.09.21

    • APIs | Solid Dosage/Creams/Ointments
      Spray Drying: A Proven Approach to Enhance the Solubility of APIs

      Spray Drying: A Proven Approach to Enhance the Solubility of APIs

      Spray drying is an established particle engineering technology that offers several advantages over other methods used for improving API bioavailability.
      Benzion Dolitzky, PhD, VP R&D, Wavelength Pharmaceuticals 09.09.21


    • Global Outsourcing Trends

      Global Outsourcing Trends

      Lonza’s Jan Vertommen talks about building global manufacturing and development networks to advance innovative, life-saving therapies.
      Tim Wright, Editor, Contract Pharma 09.09.21

    • Breaking News | Cytotoxics and High Potency Manufacturing | Industry News
      Ardena Acquires Idifarma from Suanfarma and Sodena

      Ardena Acquires Idifarma from Suanfarma and Sodena

      Adds spray drying technology and high potency capabilities.
      09.02.21

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 30
    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    MAV Beauty Recruits Former Elizabeth Arden CEO Scott Beattie
    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Happi

    Latest Breaking News From Happi

    Is Dr. Barbara Sturm Skincare Considering a Sale?
    YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
    Christian Siriano Appointed Olay’s First Chief Drop Officer
    Ink World

    Latest Breaking News From Ink World

    MicroDynamics, All Printing Resources Partner to Represent Veritas
    Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
    Siegwerk’s Climate Targets Validated by SBTi
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 30
    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login